Mutant IDH1 promotes phagocytic function of microglia/macrophages in gliomas by downregulating ICAM1-Reference-Cited by-同舟云学术

Mutant IDH1 promotes phagocytic function of microglia/macrophages in gliomas by downregulating ICAM1

Published:2021-10 Issue: Volume:517 Page:35-45
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Ma Ding,Zhan Daqian,Fu Yi,Wei Shuang,Lal Bachchu,Wang Jie,Li Yunqing,Lopez-Bertoni Hernando^ORCID,Yalcin Fatih^ORCID,Dzaye Omar,Eberhart Charles G.^ORCID,Laterra John^ORCID,Wilson Mary Ann^ORCID,Ying Mingyao,Xia Shuli

Funder

National Institute of Neurological Disorders and Stroke

National Institutes of Health

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference41 articles.

1. Glioblastoma: from molecular pathology to targeted treatment;Cloughesy;Annu. Rev. Pathol.,2014

2. The role of microglia and macrophages in glioma maintenance and progression;Hambardzumyan;Nat. Neurosci.,2016

3. The controversial role of microglia in malignant gliomas;Wei;Clin. Dev. Immunol.,2013

4. IDH1 and IDH2 mutations in gliomas;Yan;N. Engl. J. Med.,2009

5. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate;Dang;Nature,2009

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mast cell tryptase-PAR2 axis promotes ovarian fibrosis through RNF152-mediated stabilization of Bcl-xL;2024-08-12

2. Mast cell tryptase is involved in the pathogenesis of POI by inducing ovarian fibrosis via protease-activated receptor-2 signaling.;2024-08-05

3. IDH mutation, glioma immunogenicity, and therapeutic challenge of primary mismatch repair deficient IDH‐mutant astrocytoma PMMRDIA: a systematic review;Molecular Oncology;2024-02-09

4. Detection, mechanisms, and therapeutic implications of oncometabolites;Trends in Endocrinology & Metabolism;2023-12

5. CRISPR-Mediated Base Editing: Promises and Challenges for a Viable Oncotherapy Strategy;Human Gene Therapy;2023-08-01